Trial intelligence / Profile preview

CFR Assessment: Ticagrelor vs Prasugrel in ACS

NCT02032303Phase 4Unknown

Sponsor
Azienda Ospedaliero-Universitaria Policlinico Umberto I
Start
Feb 2014
Primary completion
Dec 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ticagrelor in acute coronary syndrome (ACS), sponsored by Azienda Ospedaliero-Universitaria Policlinico Umberto I. Status: unknown.

02

Drugs

ticagrelor
03

Conditions

acute coronary syndrome (ACS)

Beyond the preview

Go deeper on NCT02032303.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02032303.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call